NHLBI plans for the promise of cell-based therapies.
This article presents the National Heart, Lung and Blood Institute (NHLBI) perspective on the status of cell-based therapies. A summary of current and future NHLBI/National Institutes of Health (NIH) programs is given along with a history of the development of NHLBI/NIH resources to aid the advancement of cell-based therapies. A brief discussion of clinical research programs to utilize cell-based therapies is also included.
Mondoro
T Heath
TH
Division of Blood Diseases and Resources, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA.
Thomas
J W
JW
Henslee-Downey
P J
PJ
Peterson
C M
CM
D000818:Animals; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D054555:National Heart, Lung, and Blood Institute (U.S.); D012108:Research Personnel / Q000193:education; D033581:Stem Cell Transplantation / Q000331:legislation & jurisprudence; D013234:Stem Cells; D014481:United States